Data / Form D filings / Branch Therapeutics, Inc.
Branch Therapeutics, Inc.: Form D filing
Branch Therapeutics, Inc., a pharmaceuticals company in Houston, TX, filed a Form D with the SEC in 2025. The latest, on May 23, 2025, reports $4 million sold of a $4 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2450 HOLCOMBE BLVD, TMCI PARTNERS OFFICE 1.319, Houston, TX, 77021
- Phone
- (615) 351-1950
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2067625
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 23, 2025 | New notice | $3,999,994 | $3,999,994 | 1 | Apr 30, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sourav Banerjee | Director | |
| Curtis Thorne | Executive Officer, Director | |
| Christopher Hulme | Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
- InnovoTEX Inc. $749,951 · Aug 6, 2026
Every Form D from the week of May 19, 2025 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Branch Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.